BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 2197027)

  • 1. Pyruvate kinase deficiency.
    Miwa S; Fujii H
    Clin Biochem; 1990 Apr; 23(2):155-7. PubMed ID: 2197027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two cases of pyruvate kinase deficiency: PK 'Kamakura' and PK 'Naniwa'.
    Takegawa S; Fujii H; Takahashi K; Morisaki T; Hirono A; Takizawa T; Kanno H; Tsujino G; Miwa S
    Nihon Ketsueki Gakkai Zasshi; 1985 Sep; 48(6):1332-6. PubMed ID: 4090923
    [No Abstract]   [Full Text] [Related]  

  • 3. Red blood cell PK deficiency: An update of PK-LR gene mutation database.
    Canu G; De Bonis M; Minucci A; Capoluongo E
    Blood Cells Mol Dis; 2016 Mar; 57():100-9. PubMed ID: 26832193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated pyruvate kinase activity in patients with hemolytic anemia due to red cell pyruvate kinase "deficiency".
    Beutler E; Forman L; Rios-Larrain E
    Am J Med; 1987 Nov; 83(5):899-904. PubMed ID: 3674096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyruvate kinase deficiency.
    Miwa S
    Nihon Ketsueki Gakkai Zasshi; 1987 Dec; 50(8):1445-52. PubMed ID: 3328943
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pyruvate kinase (PK) isozyme switching and genetic heterogeneity of PK deficiency].
    Kanno H
    Nihon Rinsho; 1995 May; 53(5):1213-20. PubMed ID: 7602781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Red cell pyruvate kinase deficiency: from genetics to clinical manifestations.
    Zanella A; Bianchi P
    Baillieres Best Pract Res Clin Haematol; 2000 Mar; 13(1):57-81. PubMed ID: 10916678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Red cell pyruvate kinase deficiency: molecular and clinical aspects.
    Zanella A; Fermo E; Bianchi P; Valentini G
    Br J Haematol; 2005 Jul; 130(1):11-25. PubMed ID: 15982340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemolytic anemia due to pyruvate kinase deficiency: characterization of the enzymatic activity from eight patients.
    Black JA; Rittenberg MB; Bigley RH; Koler RD
    Am J Hum Genet; 1979 May; 31(3):300-10. PubMed ID: 463878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary structure of murine red blood cell-type pyruvate kinase (PK) and molecular characterization of PK deficiency identified in the CBA strain.
    Kanno H; Morimoto M; Fujii H; Tsujimura T; Asai H; Noguchi T; Kitamura Y; Miwa S
    Blood; 1995 Oct; 86(8):3205-10. PubMed ID: 7579416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transgenic rescue of hemolytic anemia due to red blood cell pyruvate kinase deficiency.
    Kanno H; Utsugisawa T; Aizawa S; Koizumi T; Aisaki K; Hamada T; Ogura H; Fujii H
    Haematologica; 2007 Jun; 92(6):731-7. PubMed ID: 17550844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hereditary erythrocyte pyruvate-kinase (PK) deficiency and chronic hemolytic anemia: clinical, genetic and molecular studies in six new Spanish patients.
    Vives-Corrons JL; Marie J; Pujades MA; Kahn A
    Hum Genet; 1980; 53(3):401-8. PubMed ID: 7372343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pyruvate kinase variant with an increased affinity for phosphoenolpyruvate in an individual with congenital non-spherocytic haemolytic anaemia.
    Smith O; Temperley IJ; Tipton K; McCann SR
    Clin Lab Haematol; 1983; 5(3):237-41. PubMed ID: 6653061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The molecular basis of canine pyruvate kinase deficiency.
    Whitney KM; Goodman SA; Bailey EM; Lothrop CD
    Exp Hematol; 1994 Aug; 22(9):866-74. PubMed ID: 7520391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and biochemical studies on mutant red cell enzymes mainly associated with hemolytic anemia.
    Miwa S
    Jinrui Idengaku Zasshi; 1980 Jun; 25(2):83-92. PubMed ID: 7431680
    [No Abstract]   [Full Text] [Related]  

  • 16. [Chronic non-spherocytic hemolytic anemia caused by pyruvate kinase deficiency in a Costa Rican family carrying hemoglobin C disease].
    Chaves M; Vives-Corrons JL; Sáenz GF; Pujades MA; Briceño J; Colomer D
    Sangre (Barc); 1990 Apr; 35(2):128-33. PubMed ID: 2363093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extreme deficiency of L-type pyruvate kinase with moderate clinical expression.
    Staal GE; Rijksen G; Vlug AM; Vromen-van den Bos B; Akkerman JW; Gorter G; Dierick J; Petermans M
    Clin Chim Acta; 1982 Feb; 118(2-3):241-53. PubMed ID: 7055983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyruvate kinase deficiency and other enzymopathies of the Embden--Meyerhof pathway.
    Miwa S
    Clin Haematol; 1981 Feb; 10(1):57-80. PubMed ID: 6260408
    [No Abstract]   [Full Text] [Related]  

  • 19. Pyruvate kinase "Göttingen 1,2": congenital hemolytic anemia, evidence of double heterozygosity, and lack of enzyme cooperativity.
    Schröter W; Lakomek M; Scharnetzky M; Tillmann W; Winkler H
    Hum Genet; 1982; 60(4):381-6. PubMed ID: 7106777
    [No Abstract]   [Full Text] [Related]  

  • 20. Activation of pyruvate kinase as therapeutic option for rare hemolytic anemias: Shedding new light on an old enzyme.
    van Dijk MJ; de Wilde JRA; Bartels M; Kuo KHM; Glenthøj A; Rab MAE; van Beers EJ; van Wijk R
    Blood Rev; 2023 Sep; 61():101103. PubMed ID: 37353463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.